Yili Expands its Global Health Ecosystems in Europe
PR Newswire reported that Yili, Asia’s largest and fast-growing dairy company, is joining the Open Innovation Forum, an industry network for food and FMCG companies at the Institute for Manufacturing (IfM), which is part of the University of Cambridge. Through becoming a member of the IfM’s Open Innovation Forum, Yili has a unique opportunity
Comments Off on Yili Expands its Global Health Ecosystems in Europe • Read this story »
More Articles
Four Skills For Successful Open Innovation
The Asian Scientist Magazine noted that to make sure that Open Innovation becomes deeply embedded in a company’s culture and not remain just a buzzword, certain skills are required on the part of innovation teams within corporations. We feature here four skills identified by the University of Cambridge
Comments Off on Four Skills For Successful Open Innovation • Read this story »
Four Skills For Successful Open Innovation
The Asian Scientist website reported that rather than depend solely on its own strengths and resources to innovate, organizations are beginning to realize the benefits of partnering with external collaborators for success, practicing open innovation (OI). This strategy has become something of a gold
Comments Off on Four Skills For Successful Open Innovation • Read this story »
Europe has Untapped Medical Innovation
The PharmaPhorum website noted that the ‘open innovation’ strategy is being pursued by all the big pharma companies – and now it’s simply a matter of who executes best on this approach. This is one of the boldest efforts in big pharma to create relationships with entrepreneurs, scientists and
Comments Off on Europe has Untapped Medical Innovation • Read this story »
Open Innovation in Pharma
The Genetic Engineering and Biotechnological News website posted an article which notes that as many big pharmas are maturing they have become more akin to manufacturing organizations with less internal innovation. This is where accessing science from academic centers of excellence and SMEs can help;
Comments Off on Open Innovation in Pharma • Read this story »
Will Pharma Embrace Open Innovation?
The PharmTech website notes that recent years of low approvals of new blockbuster products have given rise to the perception that pharmaceutical drug development, in its current format, no longer works. Recent late-stage failures of clinical trials have also served to emphasize the risky nature of
Comments Off on Will Pharma Embrace Open Innovation? • Read this story »